Literature DB >> 2599437

Heartburn--the acid test.

B Joelsson1, F Johnsson.   

Abstract

To determine whether symptoms of gastro-oesophageal reflux are related to the degree of oesophageal acid exposure, 190 patients (of 220 referred) with heartburn and acid regurgitation were compared with 50 normal subjects. A definite relationship between frequency of reflux symptoms and degree of oesophageal acid exposure was found both in patients with and without oesophagitis. We conclude that the frequency of gastro-oesophageal reflux symptoms is related to degree of oesophageal acid exposure.

Entities:  

Mesh:

Year:  1989        PMID: 2599437      PMCID: PMC1434330          DOI: 10.1136/gut.30.11.1523

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  Reproducibility of ambulatory oesophageal pH monitoring.

Authors:  F Johnsson; B Joelsson
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

2.  Management of dyspepsia: report of a working party.

Authors: 
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

3.  Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease.

Authors:  F Johnsson; B Joelsson; K Gudmundsson; L Greiff
Journal:  Scand J Gastroenterol       Date:  1987-08       Impact factor: 2.423

4.  The irritable oesophagus--a frequent cause of angina-like pain.

Authors:  G Vantrappen; J Janssens; G Ghillebert
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

Review 5.  Non-ulcer dyspepsia: potential causes and pathophysiology.

Authors:  N J Talley; S F Phillips
Journal:  Ann Intern Med       Date:  1988-06       Impact factor: 25.391

6.  Cimetidine responders in non-ulcer dyspepsia.

Authors:  T Johannessen; U Fjøsne; P M Kleveland; T Halvorsen; P Kristensen; I Løge; P E Hafstad; P Sandbakken; H Petersen
Journal:  Scand J Gastroenterol       Date:  1988-04       Impact factor: 2.423

  6 in total
  19 in total

1.  What is heartburn worth? A cost-utility analysis of management strategies.

Authors:  G R Heudebert; R M Centor; J C Klapow; R Marks; L Johnson; C M Wilcox
Journal:  J Gen Intern Med       Date:  2000-03       Impact factor: 5.128

2.  Clinical outcomes after laparoscopic antireflux surgery in patients with and without preoperative endoscopic esophagitis.

Authors:  Ketan M Desai; Margaret M Frisella; Nathaniel J Soper
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

Review 3.  Assessment of reflux symptom severity: methodological options and their attributes.

Authors:  P Bytzer
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 4.  Acupuncture for functional gastrointestinal disorders.

Authors:  Toku Takahashi
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

5.  Acid suppression: how much is needed?

Authors:  D G Colin-Jones
Journal:  BMJ       Date:  1990-09-22

6.  Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.

Authors:  R H Holloway; J Dent; F Narielvala; A M Mackinnon
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

7.  Quality-of-life assessments in evaluation of laparoscopic Rosetti fundoplication.

Authors:  H Glise; B Hallerbäck; B Johansson
Journal:  Surg Endosc       Date:  1995-02       Impact factor: 4.584

8.  Impaired gastric motility and its relationship to reflux symptoms in patients with nonerosive gastroesophageal reflux disease.

Authors:  Takeshi Kamiya; Hiroshi Adachi; Makoto Hirako; Michiko Shikano; Eriko Matsuhisa; Tsuneya Wada; Naotaka Ogasawara; Shunsuke Nojiri; Hiromi Kataoka; Makoto Sasaki; Hirotaka Ohara; Takashi Joh
Journal:  J Gastroenterol       Date:  2009-02-13       Impact factor: 7.527

9.  Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms.

Authors:  Kerstin Röhss; Tore Lind; Clive Wilder-Smith
Journal:  Eur J Clin Pharmacol       Date:  2004-09-02       Impact factor: 2.953

10.  Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study.

Authors:  Clive Wilder-Smith; Anna Backlund; Göran Eckerwall; Tore Lind; Mia Fjellman; Kerstin Röhss
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.